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Abstract 28	
Scope: The aim of the present study was to investigate the ability of extra virgin olive oil (EVOO) 29	
polyphenols to counteract the pro-inflammatory effects induced by dietary and endogenous 30	
oxysterols in ex-vivo immune cells.  31	
Methods and results: Peripheral blood mononuclear cells (PBMCs), separated from the whole 32	
blood of healthy donors, were utilised and were stimulated with an oxysterols mixture, in the 33	
presence of physiologically relevant concentrations of the EVOO polyphenols, hydroxytyrosol 34	
(HT), tyrosol (TYR) and homovanillic alcohol (HVA).  35	
Oxysterols significantly increased the production of pro-inflammatory cytokines, interleukin-1β 36	
(IL-1β), regulated on activation, normal T cell expressed and secreted (RANTES) and macrophage 37	
migration inhibitory factor (MIF) in ex-vivo cultured PBMCs. Increased levels of reactive oxygen 38	
species (ROS) were also detected along with increased phosphorylation of the p38 and JNK. All 39	
phenolic compounds significantly reduced cytokine secretion induced by the oxysterols and 40	
inhibited ROS production and MAPK phosphorylation.   41	
Conclusions: These results suggest that extra virgin olive oil polyphenols modulate the immune 42	
response induced by dietary and endogenous cholesterol oxidation products in human immune cells 43	
and may hold benefit in controlling chronic immune and/or inflammatory processes. 44	
 45	
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1. Introduction 55	
Oxysterols are 27-carbon-atom molecules resulting from non-enzymatic or enzymatic oxidation of 56	
cholesterol and have been detected in plasma and tissues due to endogenous formation and dietary 57	
intake [1-3]. High levels of oxysterols, generated by dysfunction in endogenous production or 58	
through high dietary intake, can affect cellular metabolism, change membrane 59	
composition/property, and promote the onset and progression of major chronic and degenerative 60	
diseases such as cancer and atherosclerosis [4, 5].  It is thought that such deleterious effects are due 61	
to their ability to trigger cytotoxic, pro-oxidative and pro-inflammatory reactions [6], such as the 62	
production of superoxide anions (O-2) and reactive oxygen species (ROS), or through their potential 63	
to enhance pro-inflammatory cytokine expression and secretion levels (tumor necrosis factor-α 64	
(TNF-α), IL-1β, IL-6, IL-8, monocyte inflammatory protein-1 (MIP-1β), cellular adhesion 65	
molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin [7]. Notably, 66	
the expression of these and other inflammatory mediators is closely dependent on the activity 67	
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-Kb), through activation of the 68	
mitogen activated protein kinase (MAPK) pathways [8].  69	
Extra virgin olive oil, the main fat source in the Mediterranean diet, with its high content in 70	
monounsaturated fatty acids and relatively high polyphenol content, may attenuate such 71	
inflammatory responses and exert beneficial effects in modulating chronic low-grade inflammation 72	
[9-13]. EVOO and its bioactive minor components, in particular, oleuropein [14, 15], 73	
hydroxytyrosol [16-21] and oleocanthal [22, 23], but also the entire phenolic fraction [24, 25], have 74	
been largely investigated in in vitro models and many findings support their anti-inflammatory and 75	
immune-modulatory effects. 76	
This is thought to occur through their capacity to limit the ROS and nitrogen species formation [16, 77	
24-28] and to inhibit the pro-inflammatory activity of ROS-generating enzymes including 78	
cyclooxygenase-2 (COX-2) [18, 24, 25, 27, 28], inducible nitric oxide synthase (iNOS) [18, 20, 24, 79	
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25, 28, 29] and to modulate different intracellular signalling pathways from NF-kB to MAPK 80	
through perturbation of redox-sensible networks in immune cells [26].  81	
Also many in vivo studies have suggested that EVOO with high phenolic concentration is effective 82	
in modulating inflammatory mediator derived from arachidonic acid, such as TBX2 and LTB4 [30-83	
33] as well as other inflammatory markers, such as high-sensitivity C-reactive protein [13, 34], IL-6 84	
[10, 34, 35], IL-β [36], IFN-λ and IL-7 [30, 37],VCAM-1, ICAM-1, TNF-α and Monocyte 85	
Chemoattractant Protein-1 (MCP-1) [10]. 86	
The aim of this study was to investigate the ability of different olive oil pure phenolic compounds, 87	
(HT, TYR and HVA), found in the blood after ingestion and absorption of EVOO, to prevent 88	
inflammatory effects induced by oxysterols in human immune cells, and to understand the 89	
implicated mechanism of action.  90	
PBMCs, separated from whole blood of healthy donors, were used for this purpose; these cells are a 91	
good model to study the inflammatory responses ex-vivo since they are composed by lymphocytes, 92	
monocytes and macrophages, critical components in the immune system to fight inflammation and 93	
source of pro-inflammatory molecules. 94	
PBMCs were treated with an oxysterols mixture composed by the most widely represented 95	
oxysterols in plasma of hypercholesterolemic subjects: 7α-hydroxycholesterol (7α-HC), 7β-96	
hydroxycholesterol (7β-HC), 7-ketocholesterol (7-KC), cholesterol 5α,6α-epoxide (5α,6α-EC), 97	
cholesterol 5β,6β-epoxide (5β,6β-EC), cholestane-3β,5α,6β-triol (triol) and 25-hydroxycholesterol 98	
(25-HC) [38] at pathologically relevant concentration (20 µM). PBMCs were used in order to 99	
investigate the ability of the olive oil simple phenols to inhibit the increase of ROS and pro-100	
inflammatory cytokine/chemokine synthesis (IL-1β, MIF and RANTES) induced by the oxysterols 101	
mixture, and to modulate the signaling pathways (MAPK) involved in these processes. 102	
 103	
 104	
 105	
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2. Materials and Methods 106	
2.1 Reagents   107	
Media and supplements were purchased from Lonza (Slough, UK). Histopaque-1077, oxysterols, 108	
2′,7′-dichlorofluorescein diacetate (DCFH-DA), horseradish peroxidase-conjugated goat anti-rabbit 109	
secondary antibody, Bradford reagent, and solvents were purchased from Sigma Aldrich (Poole, 110	
UK).  The cytokine kits were purchased from R&D systems (Abingdon, UK). Gels and all material 111	
for electrophoresis and immunoblotting were obtained from Invitrogen (Milan, Italy). The Western 112	
Blotting System was from Bio-Rad (Milan, Italy). The primary antibodies were purchased from 113	
Millipore (Watford, UK).  114	
 115	
2.2 Isolation and culture of human peripheral blood mononuclear cells 116	
The study was approved by the Ethics and Research Committee of the University of Reading 117	
(Project No. 12/16) and informed consent obtained from each blood donor.  118	
The volunteers (males and females, aged between 23 and 40 years) were enrolled according to 119	
specific inclusion (signed informed consent, men and women aged 20 – 40 years, non smokers, 120	
good general health) and exclusion criteria (history of drug abuse, including alcohol, participation 121	
in experimental trials within 3 months prior to study, use of antibiotics within the previous 3 122	
months, use of prescribed medication, regular use of anti-inflammatory drugs, any kind of 123	
inflammatory, auto-immune disease or allergy, any other pathology). 124	
Overnight fasting (12 hours) venous blood samples from 14 healthy donors were collected in the 125	
morning in sodium-heparin coated tubes (Greiner Bio-One Limited, Gloucestershire, UK). 126	
PBMCs were immediately isolated by a Ficoll-Hypaque (Histopaque-1077) density gradient from 5 127	
ml of whole peripheral blood following the manufacturer instructions and re-suspended in the 128	
culture medium consisting of RPMI 1640, 1% v/v glutamine and 1% v/v antibiotics, supplemented 129	
with autologous plasma (2.5% v/v). PBMCs were counted and cultured at 37°C in a 5% CO2 130	
humidified atmosphere. 131	
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2.3 Cell treatments for cytokines analysis 132	
PBMCs (1x106 cells/ml) were seeded in 24 well plate in complete RPMI, pre-treated or not with 133	
HT, TYR and HVA (0.25, 0.5, 1 µM) and incubated for 30 min at 37°C in a 5% CO2 atmosphere. 134	
Then, the oxysterols mixture 20 µM in ethanol was added in the medium for 24 h.  135	
An equivalent amount of ethanol was added to the control cells for all the treatments. 136	
At the end of the incubation period well contents were removed, transferred to eppendorf tubes and 137	
centrifuged to pellet the cells at 400 x g for 5 minutes at 20°C. The supernatants were collected in 138	
clean tubes and stored at -20°C until analysis. The percentage composition of the oxysterols mixture 139	
used was: 7α-HC (5%), 7β-HC (10%), 5α,6α-EC (20%), 5β,6β-EC (20%), triol (9%), 7-KC (35%), 140	
and 25-HC (1%).  141	
 142	
2.4 Measurement of cytokine/chemokines production 143	
Cytokines were preliminarily measured in cell culture supernatants (400 µl) of two samples, control 144	
and treated with the oxysterols mixture 20 µM in ethanol, by a semi-quantitative method to 145	
simultaneously detect the relative levels of 36 different cytokines and chemokines using the Human 146	
Cytokine Array Panel A (R&D systems, Abingdon, UK) following the manufacturer instructions 147	
The membranes were developed using ImageQuant LAS 4000 mini. Signal intensities of each 148	
membrane array were analyzed using the ImageQuant software (Molecular Dynamics, Amersham 149	
Pharmacia Biotech).  Three cytokines were selected for quantitative analysis by ELISA on the basis 150	
of the initial screening process described earlier. Levels of human cytokines IL-1β, MIF and 151	
RANTES were quantified using appropriate kits ("Human IL-1β/IL-1F2 DuoSet", "Human MIF 152	
DuoSet" and "Human CCL5/RANTES DuoSet" R&D systems, Abingdon, UK), following the 153	
manufacturer's instructions.  154	
 155	
2.5 Measurement of intracellular ROS production  156	
Intracellular ROS production was measured using the probe DCFH-DA.  157	
	 7	
PBMCs (1x106 cells/ml) were seeded in 24 well plate in complete RPMI. In the first set of 158	
experiments cells were incubated for 30 min with DCFH-DA 10 µM in the dark at 37°C. DCFH-159	
DA was then removed, and cells were washed with PBS and incubated with the oxysterols mixture 160	
20 µM in ethanol added in fresh medium. DCFH-DA loaded cells were immediately placed in a 161	
plate reader (Plate reader, Infinite 200, GENios TECAN) setting the excitation filter at 485 nm and 162	
the emission filter at 530 nm, with temperature maintained at 37°C. ROS production was monitored 163	
by reading the fluorescence emitted taking readings at intervals of 30 min for 3 h. In the second set 164	
of experiments cells were pre-treated or not with pure phenolic compounds, HT, TYR and HVA 165	
(0.25, 0.5, 1 µM) and incubated for 30 min at 37°C in a 5% CO2 atmosphere. Cells were then 166	
washed, treated with DCFH-DA 10 µM and incubated for 30 min in the dark at 37°C. DCFH-DA 167	
was then removed, cells were washed and incubated with the oxysterols mixture 20 µM added in 168	
fresh medium for 2 h. The fluorescence emitted from the cells was measured with the same method 169	
for 2 h. 170	
 171	
2.6. Isolation of proteins and western blot analysis of JNK 1/2 and p38 172	
PBMCs (5x106 cells/ml) were seeded in 6 well plate in complete RPMI, pre-treated or not with HT, 173	
TYR and HVA (0.25, 0.5, 1 µM) and incubated for 30 min at 37°C in a 5% CO2 atmosphere. The 174	
oxysterols mixture 20 µM in ethanol was then added in the medium and cells incubated for 3 h. 175	
Well contents were collected and centrifuged at 400 x g for 5 min at 4°C. Supernatants were 176	
discarded and cells washed/centrifuged twice with cold PBS. Finally the pellets were suspended 177	
with 150 µL of complete lysis buffer (Cell Lytic M, Sigma) with protease and phosphatase 178	
inhibitors (COmplete Ultra tablets and Mini, PhosphoSTOP, Roche) and incubated on ice for 30 179	
min (by vortexing every 10 min). At the end, lysates were centrifuged at 15000 x g for 5 min at 4°C 180	
to remove any particles or cell debris and the supernatants were collected for protein analysis. The 181	
protein concentration was determined by the Bradford protein assay [39], and 20 ug of protein 182	
sample were subjected to SDS-page and western immunoblotting as previously described [40]. The 183	
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antibodies used were anti-pp38 (1:1000 dilution), anti-p38 (1/1000 dilution), anti-pJNK 1/2 (1:200 184	
dilution), anti-JNK 1/2 (1:200 dilution) and goat anti-rabbit IgG conjugated to horseradish 185	
peroxidase (1:2000 dilution). The blots were exposed to Hyperfilm-ECL and developed with the 186	
ChemiDoc XRS Imager (BioRad). Protein bands were quantified using Image J software. 187	
 188	
2.7 Statistical analysis  189	
The statistical significance of results was evaluated by one-way ANOVA followed by Bonferroni’s 190	
multiple comparison post-test using GraphPad Prism V5 (GraphPad Software, San Diego, CA, 191	
USA). P values of <0.05 were considered statistically significant.  192	
 193	
3. Results 194	
3.1 Effect of olive oil phenolics on oxysterol-induced cytokine secretion 195	
After an initial screening with 36 cytokines with a human cytokine proteome profiler array, 3 196	
cytokines that were most significantly modulated by oxysterols were selected for further study. The 197	
levels of 3 selected cytokines (IL-1β, MIF and RANTES) were further subjected to quantitative 198	
analysis, which indicated that a 24h exposure of PBMCs to oxysterols (20 µM) resulted in a 199	
significant increase in the secretion of the pro-inflammatory cytokines/chemokines, IL-1β (Fig.1A), 200	
MIF (Fig.1B) and RANTES (Fig.1C) in PBMCs. Pre-treatment with HT, TYR and HVA (0.25, 0.5, 201	
1 µM), significantly reduced the secretion of pro-inflammatory cytokines/chemokines induced by 202	
the oxysterols.  203	
 204	
3.2 Olive oil phenolics inhibit oxysterol-induced intracellular ROS production  205	
Oxysterols (20 µM) also significantly increased intracellular ROS production over a 180 min 206	
timeframe (Fig 2). Pre-treatment of PBMCs with HT, TYR and HVA (0.25, 0.5, 1 µM) for 30 min 207	
prior to the addition of oxysterols led to a reduced intracellular ROS production at concentrations of 208	
0.5 and 1.0 µM (Fig.3), with HT and TYR significantly more active than HVA. 209	
 210	
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3.3 Effect of olive oil phenolics on redox-sensitive pathways involved in oxysterol-induced cytokine 211	
production 212	
The oxysterol mixture induced an increase in the level of the phosphorylated forms of JNK 1/2 (p-213	
JNK 1/2) in PBMCs following 3 h of exposure to PBMCs.  All polyphenols were shown to 214	
significantly attenuate these increases with the exception of HVA, at 0.5 µM. (Fig.4). Similarly, 215	
oxysterols also induced the phosphorylation of p38 in PBMCs, with all phenolic compounds 216	
counteracting these effects at the highest concentration and HT also active at 0.25 µM. 217	
 218	
4. Discussion 219	
Cholesterol oxidation products, termed oxysterols, may either originate endogenously, through 220	
enzymatic or non-enzymatic reactions, or may derive from the diet. As regards exogenous sources 221	
of oxysterols, foods containing cholesterol are susceptible to oxidation: oxidative reactions occur 222	
during food processing, mainly on exposure to heat treatment and during long-term storage [41]. 223	
They are involved in physiological processes such as the regulation of cholesterol homeostasis, but 224	
it is well established that oxysterols have mostly detrimental biological activities. They provoke an 225	
imbalance of the ratio between oxidative and reductive biochemical reactions (oxidative stress) 226	
which acts on all organism levels, from cell signalling to disease expression through up-regulation 227	
of inflammation, apoptosis and fibrosis [7, 42]. 228	
Pathological accumulation of oxysterols may contribute in fact to the onset and especially to the 229	
development of major chronic diseases in which inflammation, but also oxidative damage and to a 230	
certain extent cell death, are hallmarks and primary mechanisms of progression. Indeed, certain 231	
oxysterols exercise strong pro-oxidant and pro-inflammatory effects at concentrations detectable in 232	
the lesions typical of atherosclerosis, neurodegenerative diseases, age-related macular degeneration, 233	
and other pathological conditions characterized by altered cholesterol uptake and/or metabolism [6]. 234	
Several studies in animals and humans have shown that dietary oxysterols, after digestion can be 235	
absorbed from the gut and transported into the circulation within chylomicrons and other 236	
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lipoproteins [43, 44]. Furthermore, the presence of oxysterols in plasma can derive from the 237	
oxidation of endogenous cholesterol through enzymatic or spontaneous reactions [7]. 238	
Oxysterols have been found at increased levels in the plasma of hypercholesterolemic subjects and 239	
have been linked with the atherosclerotic process [45].  240	
This study focused on the protective effect of pure olive oil phenolics, which can be found in the 241	
blood stream after absorption (HT, TYR, and HVA) against the pro-oxidant and pro-inflammatory 242	
activity of oxysterols in immune blood cells. 243	
The phenolic compounds used in our study are bioavailable [46-49], as shown in numerous studies, 244	
and the concentrations used in this study are physiologically relevant (0.25 - 0.5 - 1 µM) [50].  245	
PBMCs separated from whole blood of healthy volunteers were used for this study; these are 246	
composed by lymphocytes, monocytes and macrophages, critical components in the immune system 247	
to fight inflammation and source of pro-inflammatory molecules. 248	
PBMCs cells were treated with an oxysterols mixture composed by the most widely represented 249	
oxysterols in plasma of hypercholesterolemic subjects: 7α-HC, 7β-HC, 7-KC, 5α,6α-EC, 5β,6β-EC, 250	
triol and 25-HC [38] at pathologically relevant concentration (20 µM). In fact, oxysterols in human 251	
plasma or serum may vary from about 1 µM (0.05% of total cholesterol) in healthy subjects to 20-252	
30 µM (0.5-0.75% of total cholesterol) in diseased individuals, but much higher concentrations of 253	
plasma oxysterols have also been reported [4, 45, 51].  254	
The first intent was to examine the ability of PBMCs to produce cytokines and chemokines in the 255	
presence of oxysterols, in particular, IL-1β, MIF and RANTES, usually involved in pro-256	
inflammatory processes; the oxysterols mixture was able to significantly increase the secretion of 257	
all cytokines/chemokines analysed. Since it has been suggested that oxysterols may increase the 258	
levels of cytokines by modulating redox-sensitive pathways [52], the oxidative status of PBMCs 259	
treated with the oxysterols mixture was then measured. An early increase (after 15 min) of 260	
intracellular ROS production was observed in PBMCs challenged with oxysterols compared to 261	
control. At moderate concentrations, ROS may act as second messengers in signal transduction, by 262	
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modulating redox-sensitive MAPK; these kinases have been already reported to be activated by 263	
various stress stimuli, including treatments with different oxysterols, 7-KC and 25-HC [52, 53] and 264	
they have been also implicated in oxysterol-induced cytokine secretion and apoptosis [6, 52, 54]. 265	
In the experimental conditions of this research, the oxysterols mixture induced a significant increase 266	
of both JNK and p38 phosphorylation suggesting their involvement in cytokine secretion. 267	
These results are in accordance with other experimental studies; for example, in human monocytic 268	
cells, 7β-HC and 25-HC, but also 7-KC to a lesser extent, are potent in vitro inducers of IL-1β, IL-269	
8, TNF-α, and MIP-1β, as well as of other inflammatory molecules [55]. The same study 270	
demonstrated that IL-8 secretion was associated with activation of the ERK 1/2 signaling pathway 271	
[55]. The oxysterols 7-KC and 25-HC have also been observed to enhance IL-1β, IL-6, IL-8, and 272	
TNF-α mRNA and secretion levels, in a dose-dependent manner, although to different extents. 273	
These effects were associated with increased ROS production, and a net phosphorylation of MAPK 274	
(ERK 1/2, JNK, p38) and NF-kB activation also occurred [52]. 275	
Up-regulation of IL-1β is another important event, because this cytokine increases the surface 276	
expression of endothelial adhesion molecules, by facilitating inflammatory cells attachment to the 277	
artery endothelium. Expression and synthesis of IL-1β were found to be stimulated by 25-HC in 278	
human macrophages, through the involvement of the liver X receptor, as well as, but less strongly, 279	
by 27-hydroxycholesterol (27-HC) [56]. IL-1β secretion was also markedly induced by 7β-HC, 7-280	
KC, and 7α-HC in human promonocytic cells U937 and U4 [57, 58] and in human umbilical vein 281	
endothelial cells (HUVECs) [59]. Production of the pro-inflammatory cytokines TNF-α and IL-1β 282	
is also induced by 25-HC in adherent human peripheral blood mononuclear leukocytes, through 283	
phosphorylation of p38 MAPK [60]. In the literature there is not any specific correlation between 284	
oxysterols and RANTES and MIF secretion; but the increased RANTES and MIF expressions have 285	
been associated with a wide range of inflammatory disorders and pathologies, such as inflammatory 286	
bowel disease and atherosclerosis where oxysterols exert a pivotal role. RANTES and MIF are 287	
cytokines with chemokine-like function and critical mediators of the host immune and 288	
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inflammatory response; they are thought to act by recruiting and promoting leukocytes infiltration 289	
to sites of inflammation [61, 62]. 290	
In this study it was demonstrated that all phenolic compounds HT, TYR and HVA at all tested 291	
concentrations, were able to inhibit oxysterol-induced pro-inflammatory cytokines production in ex-292	
vivo immune cells. According to the hypotesis that pro-inflammatory cytokines release may be 293	
induced by changes in intracellular redox status, it was observed that, in human PBMCs treated 294	
with the oxysterols mixture, simple phenols were able to inhibit ROS production significantly from 295	
the concentration of 0.5 µM as well as to suppress redox-based MAPK phosphorylation (JNK, p38). 296	
In the literature there are several studies that confirmed the anti-inflammatory activity of olive oil 297	
phenolics in different districts such as in blood cells. Differential anti-inflammatory effects of 298	
phenolic compounds from extra virgin olive oil were identified in human whole blood cultures: OL- 299	
glycoside and CA decreased the concentration of IL-1β and kaempferol decreased the concentration 300	
of PGE2 induced by LPS [15]. 301	
A recent study reported similar results in macrophages where oil phenolic extract exerted their 302	
protective effects against LPS-induced oxidative stress and inflammatory responses [24, 25]. The 303	
olive oil phenolic extract significantly decreased NO and ROS production and in addition 304	
significant down regulated iNOS, COX-2, reduced MAPK (JNK, p38) phosphorylation and 305	
prevented the nuclear NF-kB traslocation. 306	
HT inhibits iNOS and COX-2 expression in LPS-stimulated J774 cells at the transcriptional level 307	
by preventing the activation of NF-kB, signal transducer and activator of transcription 1 (STAT-1α) 308	
and interferon regulatory factor 1 (IRF-1) [16] and TYR prevented RAW 264.7 macrophages 309	
activation induced by gliadin and INFγ [63]. 310	
A recent study conducted by Palozza et al. [52] investigated the ability of lycopene, a strong 311	
antioxidant compound present in tomato, to prevent oxysterols induced pro-inflammatory cytokine 312	
cascade in human macrophages. Lycopene prevented oxysterol-induced increase in pro-313	
inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α) secretion and expression, such an effect was 314	
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accompanied by an inhibition of oxysterols-induced ROS production and MAPK activation (ERK 315	
1/2, JNK and p38). In our study, Olive oil phenolics showed similar capabilities against the harmful 316	
effects of the oxysterols mixture in ex-vivo blood cells. 317	
Further studies are needed to clarify the mechanism by which the phenolic compounds exert their 318	
protective action; however, data obtained in these experimental systems, suggested that these 319	
compounds act primarily by counteracting the initial stages of the pro-oxidant and pro-320	
inflammatory effects of oxysterols, inhibiting the formation of ROS and then all subsequent 321	
cascading effects. 322	
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Figure legends: 
 
Figure 1: Effects of HT, TYR and HVA (0.25-0.5-1 µM) on the pro-inflammatory cytokines IL-1β 
(A), MIF (B) and RANTES (C) secretion in PBMCs treated with the oxysterols mixture 20µM for 
24h. Each column represents the mean ± SD of six independent experiments. 
*** = p<0.001 vs Ctrl; a = p < 0.001, b = p< 0.01, c = p< 0.05 vs oxy  
Control value: IL-1β = 91 pg/ml, MIF = 770 pg/ml, RANTES = 2800 pg/ml  
 
Figure 2: Intracellular ROS production (expressed as fold increase) in PBMCs treated with the 
oxysterols mixture 20 µM for different incubation times (15-180 min) using the fluorescence probe 
DFC-DA 10 µM for 30 minutes. Each column represents the mean ± SD of six independent 
experiments. *** = p<0.001 vs ctrl  
 
Figure 3: Effect of HT, TYR and HVA (0.25- 0.5- 1 µM) on intracellular ROS production in 
PBMCs treated with the oxysterols mixture 20 µM for 2 h. Each column represents the mean ± SD 
of six independent experiments. 
*** = p<0.001 vs Ctrl; a = p<0.001, b = p<0.01, c = p<0.05 vs Oxy  
 
Figure 4: Modulation of JNK 1/2 in PBMCs pre-treated or not for 30 min with HT, TYR and HVA 
(0.25-1 µM) and incubated with the oxysterols mixture 20 µM for 3h. Each column represents the 
mean ± SD of three independent experiments. ***= p<0.001 vs Ctrl; a = p<0.001 vs Oxy  
 
Figure 5: Modulation of p38 in PBMCs pre-treated or not for 30 min with HT, TYR and HVA 
(0.25-1 µM) and incubated with the oxysterols mixture 20 µM for 3h. Each column represents the 
mean ± SD of three independent experiments. 
***= p<0.001 vs Ctrl; a = p<0.001, c = p<0.05 vs Oxy  
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